Genomic technology is the key to a longer and healthier life
The average US adult has a 40% chance of developing cancer in their lifetime, and genomic technology provides the ability to catch it early, when it is easier to treat. As the cost of genetic sequencing has decreased, the sophistication of data and AI has increased exponentially. Serenity is combining these two worlds and creating a new level of personalized medicine.
Serenity uses data and intelligence to proactively protect your health rather than reacting to illness. We are committed to making this level of advanced care the new standard.
Furthering our mission to extend the healthy human lifespan by a decade within a decade, Serenity is proud to support American Cancer Society as a community partner.
Together, we're unlocking the power of genomic medicine in the fight against cancer.
Powered by Quantgene
Serenity is powered by a vertically integrated technology stack that enables us to efficiently turn data and intelligence into medically actionable preventative guidance for members.
The vastly larger file sizes generated and used in deep genomics required a redesigned data infrastructure vs. conventional sequencing. Serenity uses a proprietary software infrastructure that connects a new database system, improved signal processing and analytical tools to accelerate data processing by over 1,000X vs. conventional systems.
The Alpha Lab
The Alpha Lab is Serenity's Portland genomics R&D and processing facility. Multiple clinical trials at The Alpha Lab continue to provide us with valuable insights into early cancer detection patterns and cell-free DNA.
The Apollo Matrix
The Apollo Matrix generates over 10 billion data points per patient. This data is generated across genomic sequencing, personal medical history, family medical history, blood panels, and millions of medical research publications. Apollo's massive data set is the foundation for seeing each individual's health in high-definition and translated into actionable and meaningful medical intelligence.
Pattern Recognition Unit
Serenity's Berlin-based bioinformatics and data lab specializes in identifying possible patterns that signal cancer or other diseases using a new generation of genomics-based AI. Through customized feature engineering systems, classical machine learning algorithms and a new form of deep learning, Serenity can deliver some of the most effective disease detection capabilities in modern medicine.